Bayer AG - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Bayer AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting Bayer AG in the form of a SWOT analysis
An in-depth view of the business model of Bayer AG including a breakdown and examination of key business segments
Intelligence on Bayer AG’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Bayer AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Bayer (or 'the group') is a Germany-based global chemical and pharmaceutical business group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. Bayer is headquartered in Leverkusen, Germany, and employed about 118,900 people as on December 31, 2014. The group recorded revenues of E42,239 million (approximately $56,135.6 million) during the financial year ended December 2014 (FY2014), an increase of 5.2% over FY2013. The operating profit of the group was E5,506 million (approximately $7,317.5 million) in FY2014, an increase of 11.6% over FY2013. The net profit of the group was E3,426 million (approximately $4,553.2 million) in FY2014, an increase of 7.4% over FY2013.
Reasons to Purchase:
Gain understanding of Bayer AG and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Bayer AG as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Bayer AG’s business structure, strategy and prospects